KIVALITA CONSULTING

Biweekly News about the life science market! 19/01/2021

Article image
Compartilhe

Record on imports of chemicals

Brazil imported US$ 3.9 billion in chemicals in November, according to information from the Brazilian Chemical Industry Association (Abiquim), and the value represents increases of 10.5% compared to October this year and 10.6% compared to November 2019.

A year after Avon, Natura & Co already has new big dream: conquering China

Company doubles value after merger with Avon, to more than R$ 70 billion, and organizes plans to accelerate international progress

GlaxoSmithKline and Vir Biotechnology announce study to evaluate early treatment of Covid-19

GlaxoSmithKline (GSK) and Vir Biotechnology have announced an agreement on the AGILE platform in the UK to assess, in a phase 1b/2a clinical trial, the use of VIR-7832 in patients with Covid-19 with mild and moderate symptoms.

Butantan will have to submit remaining data to Anvisa by February 28

The Butantan Institute, responsible for the production of coronavac vaccine in Brazil, must present, by February 28, remaining studies requested by the National Health Surveillance Agency (Anvisa) on the performance of the immunizer.

Lack of raw material for Coronavac and Oxford vaccine threatens to delay immunization in Brazil

The difficulties in importing doses and insums to produce vaccines are a major threat to the Brazilian immunization campaign, which began the day before yesterday in São Paulo. For specialists, there is a real risk that vaccination against covid-19 will be stopped in a short time due to a total lack of immunizers.

 

Sign up for our Newsletter and be the first to know about the Life Science market!

    Endereço
  • Rua dos Três Irmãos, 310 - Sala 302 - Vila Progredior
    São Paulo - SP
© 2020 Kivalita Consulting | Todos os direitos reservados